Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

448.60 -8.24 (-1.80%)
Streaming Delayed Price Updated: 3:37 PM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 317,336
Open 456.52
Bid (Size) 447.69 (1)
Ask (Size) 448.60 (3)
Prev. Close 456.84
Today's Range 444.00 - 456.52
52wk Range 266.98 - 459.48
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Growth Stocks with All-Star Potential and 1 Facing Headwinds
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings... 
Via Benzinga

Performance

YTD
+24.5%
+24.5%
1 Month
+13.7%
+13.7%
3 Month
+52.4%
+52.4%
6 Month
+60.4%
+60.4%
1 Year
+28.2%
+28.2%

More News

Read More
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
From United Therapeutics Corporation
Via Business Wire
1 Momentum Stock to Target This Week and 2 We Brush Off
Via StockStory
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results
Via Stocktwits
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
Via Stocktwits
3 Big Reasons to Love United Therapeutics (UTHR)
Via StockStory
Topics Stocks
United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Top Peter Lynch-Style GARP Investment
Via Chartmill
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
From United Therapeutics Corporation
Via Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
Via Investor's Business Daily
Topics ETFs
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio?
Via Benzinga
United Therapeutics Corp (NASDAQ:UTHR): A Prime Value Investing Candidate with Strong Fundamentals
Via Chartmill
Here are the top movers in Tuesday's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results
Via Benzinga
Topics Stocks
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
Via Chartmill
Why Is United Therapeutics Stock Rallying On Tuesday?
Via Benzinga
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It
Via Investor's Business Daily
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From United Therapeutics Corporation
Via Business Wire

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 448.60
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 10/08/25 03:37 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 20.14B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 20B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.